Business
PURE Bioscience Welcomes New Members to Board of Directors and Scientific Advisory Board
PURE Bioscience Welcomes New Members to Board of Directors and Scientific Advisory Board.
About this update from Pure Bioscience
[{"type":"text","content":"\nPURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today announced the addition of three new members to the Board of Directors with the election of Kristin A. Taylor, David M. Rendall and Tom Myers. Ms. Taylor and Mr. Rendall also will serve on the audit and compensation committees of the Board of Directors. PURE also is pleased to announce the appointment of Dr. Scott Harris and Dr. Martin Wiedmann to the Scientific Advisory Board.\n\nNew Members of Board of Directors\n\nKristin A. Taylor is an accomplished technology executive with over 20 years of experience that includes VP and Director roles at leading tech companies. In May 2020, Ms. Taylor was named President and CEO of ImageWare Systems, Inc., a software SaaS leader in biometric identification and authentication for state, local, federal governments, including law enforcement/public safety, as well as commercial businesses in the financial, healthcare, education, manufacturing and call center verticals. Prior to serving as President and Chief Executive Officer of ImageWare Systems, Ms. Taylor was a strategy consultant providing advisory services on communications, marketing, and analyst relations for Veritas Lux and Kristin A. Taylor Consulting, in which she developed a proprietary algorithmic methodology to weigh and rank the most influential global technical analysts. From September 2017 to April 2019, Ms. Taylor served as Vice President of Worldwide Analyst Relations at IBM and led the efforts to modernize and transform IBM’s Analyst Relations organization to drive not only influence but materialize revenue. From August 2013 to August 2017, she served as Vice President, Global Analyst and Public Relations at MediaTek, the third largest fabless semiconductor company worldwide with a $49 billion market cap, where she led the buildout of a new global Public and Analyst Relations organization to penetrate the North American, European, Latin American, Russian and Indian markets. Prior to that, from September 1998 to December 2010, she served in various positions of increasing responsibility with Qualcomm, including Head of Industry Analyst Relations, Senior Director of Business Development, and as a Director in Information Technology. During her tenure with Qualcomm, she drove development and launch...